Goodwill of SANGAMO THERAPEUTICS, INC from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
SANGAMO THERAPEUTICS, INC quarterly Goodwill in USD history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • SANGAMO THERAPEUTICS, INC Goodwill for the quarter ending 31 Dec 2024 was $0.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

SANGAMO THERAPEUTICS, INC Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $0 $0 31 Dec 2024 10-K 17 Mar 2025 2024 FY
Q4 2023 $0 -$37,552,000 -100% 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q3 2023 $0 -$34,511,000 -100% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $0 -$36,702,000 -100% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $0 -$38,935,000 -100% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $37,552,000 -$2,150,000 -5.4% 31 Dec 2022 10-K 17 Mar 2025 2024 FY
Q3 2022 $34,511,000 -$6,019,000 -15% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $36,702,000 -$4,799,000 -12% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $38,935,000 -$2,059,000 -5% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $39,702,000 -$3,096,000 -7.2% 31 Dec 2021 10-K 13 Mar 2024 2023 FY
Q3 2021 $40,530,000 -$454,000 -1.1% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $41,501,000 +$2,183,000 +5.6% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $40,994,000 +$2,444,000 +6.3% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $42,798,000 +$3,525,000 +9% 31 Dec 2020 10-K 23 Feb 2023 2022 FY
Q3 2020 $40,984,000 +$2,714,000 +7.1% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 $39,318,000 -$477,000 -1.2% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $38,550,000 -$733,000 -1.9% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $39,273,000 -$771,000 -1.9% 31 Dec 2019 10-K 24 Feb 2022 2021 FY
Q3 2019 $38,270,000 +$36,685,000 +2315% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $39,795,000 +$38,210,000 +2411% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $39,283,000 +$37,698,000 +2378% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $40,044,000 +$38,459,000 +2426% 31 Dec 2018 10-K 24 Feb 2021 2020 FY
Q3 2018 $1,585,000 $0 0% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 $1,585,000 $0 0% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 $1,585,000 $0 0% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $1,585,000 $0 0% 31 Dec 2017 10-K 28 Feb 2020 2019 FY
Q3 2017 $1,585,000 $0 0% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 $1,585,000 $0 0% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $1,585,000 $0 0% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 $1,585,000 $0 0% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 $1,585,000 $0 0% 30 Sep 2016 10-Q 27 Oct 2016 2016 Q3
Q2 2016 $1,585,000 $0 0% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 $1,585,000 $0 0% 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 $1,585,000 $0 0% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q3 2015 $1,585,000 $0 0% 30 Sep 2015 10-Q 30 Oct 2015 2015 Q3
Q2 2015 $1,585,000 $0 0% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 $1,585,000 $0 0% 31 Mar 2015 10-Q 28 Apr 2015 2015 Q1
Q4 2014 $1,585,000 $0 0% 31 Dec 2014 10-Q 30 Oct 2015 2015 Q3
Q3 2014 $1,585,000 30 Sep 2014 10-Q 28 Oct 2014 2014 Q3
Q2 2014 $1,585,000 30 Jun 2014 10-Q 29 Jul 2014 2014 Q2
Q1 2014 $1,585,000 31 Mar 2014 10-Q 07 May 2014 2014 Q1
Q4 2013 $1,585,000 31 Dec 2013 10-K 25 Feb 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.